Todd A Hardy

Summary

Affiliation: University of Sydney
Country: Australia

Publications

  1. doi Guillain-barré syndrome: modern theories of etiology
    Todd A Hardy
    Department of Neurology, Concord Hospital, Sydney, Australia
    Curr Allergy Asthma Rep 11:197-204. 2011
  2. doi Baló's concentric sclerosis and tumefactive demyelination: a shared immunopathogenesis?
    Todd A Hardy
    MS Australia Clinic, Brain and Mind Research Institute, University of Sydney, NSW, Australia Neuroimmunology Clinic, Concord Repatriation General Hospital, Sydney, NSW, Australia Electronic address
    J Neurol Sci 348:279-81. 2015
  3. doi Baló's concentric sclerosis
    Todd A Hardy
    Neuroimmunology Clinic, Department of Neurology, Concord Repatriation General Hospital, University of Sydney, NSW, Australia MS Australia Clinic, Brain and Mind Research Institute, Sydney, NSW, Australia Electronic address
    Lancet Neurol 13:740-6. 2014
  4. doi Tumefactive demyelination: an approach to diagnosis and management
    Todd A Hardy
    Department of Neuroinflammation, National Hospital for Neurology and Neurosurgery, London, UK
    J Neurol Neurosurg Psychiatry 84:1047-53. 2013
  5. doi Severe Bickerstaff's encephalitis treated with Rituximab: serum and CSF GQ1b antibodies
    Todd A Hardy
    Department of Neuroinflammation, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK
    J Neuroimmunol 251:107-9. 2012
  6. doi Tumour necrosis factor (TNF) inhibitor therapy in Susac's syndrome
    T A Hardy
    Department of Neurology, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW, 2050, Australia
    J Neurol Sci 302:126-8. 2011
  7. doi The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases
    Nidhi Garg
    Neuroimmunology Clinic, Concord Hospital and University of Sydney, Sydney, New South Wales, Australia
    J Neurol Neurosurg Psychiatry 86:1374-82. 2015
  8. doi Distinguishing Susac's syndrome from multiple sclerosis
    Katherine A Buzzard
    Neuroimmunology Clinic, Concord Hospital, University of Sydney, Sydney, NSW, Australia
    J Neurol 262:1613-21. 2015

Collaborators

Detail Information

Publications8

  1. doi Guillain-barré syndrome: modern theories of etiology
    Todd A Hardy
    Department of Neurology, Concord Hospital, Sydney, Australia
    Curr Allergy Asthma Rep 11:197-204. 2011
    ....
  2. doi Baló's concentric sclerosis and tumefactive demyelination: a shared immunopathogenesis?
    Todd A Hardy
    MS Australia Clinic, Brain and Mind Research Institute, University of Sydney, NSW, Australia Neuroimmunology Clinic, Concord Repatriation General Hospital, Sydney, NSW, Australia Electronic address
    J Neurol Sci 348:279-81. 2015
    ..The nature of BCS and TD in relation to more typical multiple sclerosis is discussed...
  3. doi Baló's concentric sclerosis
    Todd A Hardy
    Neuroimmunology Clinic, Department of Neurology, Concord Repatriation General Hospital, University of Sydney, NSW, Australia MS Australia Clinic, Brain and Mind Research Institute, Sydney, NSW, Australia Electronic address
    Lancet Neurol 13:740-6. 2014
    ....
  4. doi Tumefactive demyelination: an approach to diagnosis and management
    Todd A Hardy
    Department of Neuroinflammation, National Hospital for Neurology and Neurosurgery, London, UK
    J Neurol Neurosurg Psychiatry 84:1047-53. 2013
    ..We argue that disease modifying therapy should be considered for acute tumefactive demyelinating lesions only once criteria of dissemination in time and space are fulfilled and the diagnosis of multiple sclerosis is confirmed. ..
  5. doi Severe Bickerstaff's encephalitis treated with Rituximab: serum and CSF GQ1b antibodies
    Todd A Hardy
    Department of Neuroinflammation, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK
    J Neuroimmunol 251:107-9. 2012
    ..There was a concomitant reduction in serum GQ1b antibodies associated with improvement. Interestingly, GQ1b antibody was also detected in CSF. These findings have potentially significant clinical and immunopathological implications...
  6. doi Tumour necrosis factor (TNF) inhibitor therapy in Susac's syndrome
    T A Hardy
    Department of Neurology, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW, 2050, Australia
    J Neurol Sci 302:126-8. 2011
    ..2008, Lee and Amezcua 2009) [3,4]. We report a case of Susac's syndrome in which the patient improved immediately after tumour necrosis factor (TNF) inhibition with the monoclonal antibody, infliximab...
  7. doi The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases
    Nidhi Garg
    Neuroimmunology Clinic, Concord Hospital and University of Sydney, Sydney, New South Wales, Australia
    J Neurol Neurosurg Psychiatry 86:1374-82. 2015
    ..An understanding of the appearance and location of lesions in the CC is important not only for accurate diagnosis and treatment of these various conditions, but as it also provides insights into pathogenesis. ..
  8. doi Distinguishing Susac's syndrome from multiple sclerosis
    Katherine A Buzzard
    Neuroimmunology Clinic, Concord Hospital, University of Sydney, Sydney, NSW, Australia
    J Neurol 262:1613-21. 2015
    ..In this article, we discuss the clinical features of Susac's syndrome with emphasis on the findings and investigations that help to differentiate it from MS. ..